Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Kevin Bielamowicz

Concepts (136)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Medulloblastoma
4
2022
17
1.220
Why?
Brain Neoplasms
10
2024
282
1.180
Why?
Glioblastoma
6
2018
88
1.150
Why?
Histiocytosis, Langerhans-Cell
2
2024
30
1.130
Why?
T-Lymphocytes
7
2023
330
0.990
Why?
RNA-Binding Protein EWS
1
2024
14
0.930
Why?
Interleukin-13 Receptor alpha2 Subunit
3
2018
4
0.910
Why?
Neoplasms, Germ Cell and Embryonal
1
2024
36
0.900
Why?
Central Nervous System Neoplasms
1
2024
64
0.880
Why?
Craniospinal Irradiation
2
2021
9
0.840
Why?
Receptors, Antigen, T-Cell
4
2018
49
0.810
Why?
Hypothyroidism
2
2021
54
0.790
Why?
Receptor, erbB-2
3
2018
74
0.760
Why?
Neoplasm Recurrence, Local
3
2024
627
0.750
Why?
Protons
2
2021
67
0.660
Why?
Antigenic Variation
2
2018
3
0.660
Why?
Receptor, EphA2
1
2018
5
0.620
Why?
Cerebellar Neoplasms
3
2022
23
0.450
Why?
Neuroblastoma
2
2024
53
0.430
Why?
Cancer Vaccines
3
2021
78
0.380
Why?
Testicular Hydrocele
1
2010
4
0.360
Why?
Thrombocytopenia
1
2011
79
0.360
Why?
Genital Diseases, Female
1
2010
17
0.360
Why?
Hernia, Inguinal
1
2010
18
0.360
Why?
Vagina
1
2010
44
0.350
Why?
Child
13
2024
6838
0.320
Why?
Immunotherapy
4
2024
237
0.320
Why?
Neoplasms
3
2023
1233
0.310
Why?
Humans
24
2024
49863
0.300
Why?
Rhabdoid Tumor
1
2024
11
0.230
Why?
Child, Preschool
6
2024
3872
0.230
Why?
Immunotherapy, Adoptive
3
2023
157
0.230
Why?
Neoplastic Syndromes, Hereditary
1
2024
16
0.230
Why?
Eyelid Diseases
1
2024
12
0.230
Why?
Xenograft Model Antitumor Assays
3
2020
212
0.220
Why?
Gene Rearrangement
1
2024
73
0.220
Why?
Tumor Cells, Cultured
3
2020
460
0.220
Why?
Glioma
1
2024
77
0.220
Why?
Bacterial Infections
1
2023
93
0.210
Why?
Bacteremia
1
2023
90
0.210
Why?
Rhabdomyosarcoma, Alveolar
1
2022
8
0.210
Why?
Sarcoma, Ewing
1
2022
27
0.200
Why?
Female
11
2024
26520
0.200
Why?
Proton Therapy
1
2021
11
0.200
Why?
Male
9
2024
25439
0.190
Why?
Adrenal Insufficiency
1
2021
18
0.190
Why?
Hematologic Neoplasms
1
2023
98
0.190
Why?
Leukemia
1
2021
64
0.190
Why?
DNA-Binding Proteins
1
2024
418
0.190
Why?
Sepsis
1
2023
220
0.180
Why?
Mice, SCID
2
2018
173
0.180
Why?
Hypothalamic Diseases
1
2020
1
0.180
Why?
Ependymoma
1
2020
7
0.180
Why?
Cerebrospinal Fluid
1
2020
30
0.180
Why?
Methylphenidate
1
2020
77
0.170
Why?
Infant
3
2024
3565
0.170
Why?
Weight Loss
1
2020
239
0.150
Why?
Mice, Inbred NOD
1
2018
94
0.150
Why?
Central Nervous System Stimulants
1
2020
207
0.150
Why?
Antineoplastic Agents
2
2024
1173
0.150
Why?
Cell Proliferation
2
2018
999
0.140
Why?
Receptors, Cell Surface
1
2017
123
0.140
Why?
Diagnosis, Differential
3
2024
1038
0.140
Why?
Tumor Escape
1
2016
16
0.140
Why?
Mice
4
2020
5671
0.130
Why?
Apoptosis
2
2018
1102
0.130
Why?
Neoplasm Proteins
1
2017
322
0.130
Why?
Adolescent
3
2024
6392
0.110
Why?
Cell Nucleus
1
2014
187
0.110
Why?
Retrospective Studies
3
2021
6106
0.110
Why?
Up-Regulation
1
2014
448
0.100
Why?
Plasma Cell Granuloma, Pulmonary
1
2011
1
0.100
Why?
Septo-Optic Dysplasia
1
2011
2
0.100
Why?
Moyamoya Disease
1
2011
7
0.100
Why?
Lung Neoplasms
1
2017
600
0.100
Why?
Obesity
1
2020
1101
0.100
Why?
Slipped Capital Femoral Epiphyses
1
2011
8
0.100
Why?
Tumor Microenvironment
2
2024
221
0.100
Why?
Medical History Taking
1
2011
47
0.100
Why?
Animals
4
2020
13133
0.090
Why?
Ultrasonography
1
2010
428
0.080
Why?
Antigens, Neoplasm
2
2021
151
0.080
Why?
Prognosis
3
2020
1948
0.080
Why?
MutS Homolog 2 Protein
1
2024
12
0.060
Why?
DNA Mismatch Repair
1
2024
16
0.060
Why?
Chalazion
1
2024
3
0.060
Why?
CTLA-4 Antigen
1
2024
23
0.060
Why?
Follow-Up Studies
2
2020
2174
0.060
Why?
Survival Rate
2
2017
904
0.060
Why?
Fever
1
2023
110
0.050
Why?
Maximum Tolerated Dose
1
2022
38
0.050
Why?
Biopsy
1
2024
591
0.050
Why?
Glucocorticoids
1
2024
228
0.050
Why?
Longitudinal Studies
1
2024
693
0.050
Why?
Adult
3
2024
13325
0.050
Why?
Growth Hormone
1
2021
95
0.050
Why?
Incidence
1
2024
982
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
225
0.050
Why?
Radiotherapy Dosage
1
2021
246
0.050
Why?
Colorectal Neoplasms
1
2024
253
0.050
Why?
Injections, Intraventricular
1
2020
13
0.040
Why?
HEK293 Cells
1
2020
213
0.040
Why?
Neoplasm Metastasis
1
2020
235
0.040
Why?
Cross-Sectional Studies
1
2024
1568
0.040
Why?
Drug Delivery Systems
1
2020
142
0.040
Why?
Treatment Outcome
2
2020
5165
0.040
Why?
Mutation
1
2024
1290
0.040
Why?
Anti-Bacterial Agents
1
2023
743
0.040
Why?
Microfilament Proteins
1
2017
42
0.040
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2024
993
0.040
Why?
Prospective Studies
1
2023
2341
0.040
Why?
Adenoviridae
1
2017
51
0.040
Why?
Cytomegalovirus
1
2017
27
0.040
Why?
Herpesvirus 4, Human
1
2017
39
0.040
Why?
Interleukin-13
1
2016
15
0.030
Why?
Neoplasm Transplantation
1
2016
84
0.030
Why?
Transgenes
1
2016
52
0.030
Why?
Infant, Newborn
1
2024
2725
0.030
Why?
Protein Multimerization
1
2016
50
0.030
Why?
Lymphocyte Activation
1
2016
171
0.030
Why?
Protein Binding
1
2016
653
0.030
Why?
Case-Control Studies
1
2017
1129
0.030
Why?
Young Adult
1
2024
4013
0.030
Why?
Adoptive Transfer
1
2014
40
0.030
Why?
Cell Cycle
1
2014
225
0.030
Why?
Recurrence
1
2014
658
0.030
Why?
Cell Line, Tumor
1
2016
1387
0.030
Why?
Groin
1
2011
16
0.020
Why?
Cough
1
2011
54
0.020
Why?
Hypoglycemia
1
2011
52
0.020
Why?
Penis
1
2011
79
0.020
Why?
Anemia, Sickle Cell
1
2011
94
0.020
Why?
Radiography
1
2011
485
0.020
Why?
Pain
1
2011
374
0.020
Why?
Aged
1
2017
9434
0.010
Why?
Middle Aged
1
2017
12258
0.010
Why?
Bielamowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description